Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jul 27, 2022; 14(7): 670-684
Published online Jul 27, 2022. doi: 10.4240/wjgs.v14.i7.670
Published online Jul 27, 2022. doi: 10.4240/wjgs.v14.i7.670
CKD stage | P value | ||
RD (EGFR < 60), n = 128 | Non-RD (EGFR ≥ 60), n = 672 | ||
All complications | 33 (25.8) | 169 (25.1) | 0.96 |
Major complication (Grade ≥ 2) | 20 (15.6) | 112 (16.7) | 0.91 |
Bile leakage | 12 (9.8) | 44 (6.5) | 0.33 |
Ascites | 6 (4.7) | 27 (4.0) | 0.90 |
Pleural effusion | 4 (3.1) | 37 (5.5) | 0.41 |
Pneumonia | 6 (5.3) | 12 (1.8) | 0.70 |
Bleeding | 7 (5.5) | 12 (1.8) | < 0.05 |
Liver failure | 1 (0.8) | 9 (1.3) | 0.55 |
Surgical site infection | 5 (3.9) | 12 (1.8) | < 0.05 |
Duration of postoperative hospital stay (d) | 16.0 ± 14.5 | 16.0 ± 19.3 | 0.17 |
Died during hospitalization | 11 (0.8) | 12 (0.1) | 0.96 |
- Citation: Sakamoto Y, Shimada S, Kamiyama T, Sugiyama K, Asahi Y, Nagatsu A, Orimo T, Kakisaka T, Kamachi H, Ito YM, Taketomi A. Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection. World J Gastrointest Surg 2022; 14(7): 670-684
- URL: https://www.wjgnet.com/1948-9366/full/v14/i7/670.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i7.670